The University of Chicago Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gregory Karczmar and Xiaobing Fan.
Gregory Karczmar
Connection Strength
12.025
Xiaobing Fan
  1. Introduction to matrix-based method for analyzing hybrid multidimensional prostate MRI data. J Appl Clin Med Phys. 2024 Nov 20; e14544.
    View in: PubMed
    Score: 0.994
  2. Signal intensity form of the Tofts model for quantitative analysis of prostate dynamic contrast enhanced MRI data. Phys Med Biol. 2021 01 22; 66(2):025002.
    View in: PubMed
    Score: 0.762
  3. Correlation of In Vivo and Ex Vivo ADC and T2 of In Situ and Invasive Murine Mammary Cancers. PLoS One. 2015; 10(7):e0129212.
    View in: PubMed
    Score: 0.521
  4. Mammary cancer initiation and progression studied with magnetic resonance imaging. Breast Cancer Res. 2014 Dec 16; 16(6):495.
    View in: PubMed
    Score: 0.499
  5. Use of a reference tissue and blood vessel to measure the arterial input function in DCEMRI. Magn Reson Med. 2010 Dec; 64(6):1821-6.
    View in: PubMed
    Score: 0.377
  6. Can DCEMRI assess the effect of green tea on the angiogenic properties of rodent prostate tumors? Phys Med. 2010 Apr; 26(2):111-6.
    View in: PubMed
    Score: 0.344
  7. A new approach to analysis of the impulse response function (IRF) in dynamic contrast-enhanced MRI (DCEMRI): a simulation study. Magn Reson Med. 2009 Jul; 62(1):229-39.
    View in: PubMed
    Score: 0.342
  8. Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: qualitative and quantitative comparisons. J Magn Reson Imaging. 2006 Dec; 24(6):1311-5.
    View in: PubMed
    Score: 0.286
  9. MRI of perfluorocarbon emulsion kinetics in rodent mammary tumours. Phys Med Biol. 2006 Jan 21; 51(2):211-20.
    View in: PubMed
    Score: 0.268
  10. New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors. Magn Reson Med. 2004 Mar; 51(3):487-94.
    View in: PubMed
    Score: 0.236
  11. Four-quadrant vector mapping of hybrid multidimensional MRI data for the diagnosis of prostate cancer. Med Phys. 2024 Mar; 51(3):2057-2065.
    View in: PubMed
    Score: 0.228
  12. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer. Magn Reson Imaging. 2023 Dec; 104:9-15.
    View in: PubMed
    Score: 0.228
  13. Parametric maps of spatial two-tissue compartment model for prostate dynamic contrast enhanced MRI - comparison with the standard tofts model in the diagnosis of prostate cancer. Phys Eng Sci Med. 2023 Sep; 46(3):1215-1226.
    View in: PubMed
    Score: 0.226
  14. Effect of carbogen on tumor oxygenation: combined fluorine-19 and proton MRI measurements. Int J Radiat Oncol Biol Phys. 2002 Nov 15; 54(4):1202-9.
    View in: PubMed
    Score: 0.216
  15. Structure of the water resonance in small voxels in rat brain detected with high spectral and spatial resolution MRI. J Magn Reson Imaging. 2002 Nov; 16(5):547-52.
    View in: PubMed
    Score: 0.216
  16. Directional and inter-acquisition variability in diffusion-weighted imaging and editing for restricted diffusion. Magn Reson Med. 2022 11; 88(5):2298-2310.
    View in: PubMed
    Score: 0.211
  17. Effectiveness of Dynamic Contrast Enhanced MRI with a Split Dose of Gadoterate Meglumine for Detection of Prostate Cancer. Acad Radiol. 2022 06; 29(6):796-803.
    View in: PubMed
    Score: 0.200
  18. Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn Reson Med. 2001 Jun; 45(6):1046-55.
    View in: PubMed
    Score: 0.195
  19. Comparison of DCE-MRI of murine model cancers with a low dose and high dose of contrast agent. Phys Med. 2021 Jan; 81:31-39.
    View in: PubMed
    Score: 0.190
  20. Magnetic resonance angiography reveals increased arterial blood supply and tumorigenesis following high fat feeding in a mouse model of triple-negative breast cancer. NMR Biomed. 2020 10; 33(10):e4363.
    View in: PubMed
    Score: 0.185
  21. A compact solution for estimation of physiological parameters from ultrafast prostate dynamic contrast enhanced MRI. Phys Med Biol. 2019 08 07; 64(15):155012.
    View in: PubMed
    Score: 0.172
  22. Use of Indicator Dilution Principle to Evaluate Accuracy of Arterial Input Function Measured With Low-Dose Ultrafast Prostate Dynamic Contrast-Enhanced MRI. Tomography. 2019 06; 5(2):260-265.
    View in: PubMed
    Score: 0.170
  23. Magnetic Resonance Angiography Shows Increased Arterial Blood Supply Associated with Murine Mammary Cancer. Int J Biomed Imaging. 2019; 2019:5987425.
    View in: PubMed
    Score: 0.166
  24. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis. Invest Radiol. 2018 10; 53(10):609-615.
    View in: PubMed
    Score: 0.162
  25. Comparison of arterial input functions measured from ultra-fast dynamic contrast enhanced MRI and dynamic contrast enhanced computed tomography in prostate cancer patients. Phys Med Biol. 2018 01 30; 63(3):03NT01.
    View in: PubMed
    Score: 0.155
  26. Magnetic resonance spectroscopy detects differential lipid composition in mammary glands on low fat, high animal fat versus high fructose diets. PLoS One. 2018; 13(1):e0190929.
    View in: PubMed
    Score: 0.154
  27. Comparison of region-of-interest-averaged and pixel-averaged analysis of DCE-MRI data based on simulations and pre-clinical experiments. Phys Med Biol. 2017 Sep 05; 62(18):N445-N459.
    View in: PubMed
    Score: 0.151
  28. MRI reveals increased tumorigenesis following high fat feeding in a mouse model of triple-negative breast cancer. NMR Biomed. 2017 Oct; 30(10).
    View in: PubMed
    Score: 0.149
  29. MRI ductography of contrast agent distribution and leakage in normal mouse mammary ducts and ducts with in situ cancer. Magn Reson Imaging. 2017 07; 40:48-52.
    View in: PubMed
    Score: 0.146
  30. Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis. Acad Radiol. 2016 09; 23(9):1137-44.
    View in: PubMed
    Score: 0.138
  31. Arterial input functions (AIFs) measured directly from arteries with low and standard doses of contrast agent, and AIFs derived from reference tissues. Magn Reson Imaging. 2016 Feb; 34(2):197-203.
    View in: PubMed
    Score: 0.133
  32. MRI accurately identifies early murine mammary cancers and reliably differentiates between in situ and invasive cancer: correlation of MRI with histology. NMR Biomed. 2015 Sep; 28(9):1078-86.
    View in: PubMed
    Score: 0.130
  33. B1 and T1 mapping of the breast with a reference tissue method. Magn Reson Med. 2016 Apr; 75(4):1565-73.
    View in: PubMed
    Score: 0.129
  34. Comparison of dynamic contrast-enhanced MRI parameters of breast lesions at 1.5 and 3.0?T: a pilot study. Br J Radiol. 2015 May; 88(1049):20150021.
    View in: PubMed
    Score: 0.127
  35. High resolution 3D MRI of mouse mammary glands with intra-ductal injection of contrast media. Magn Reson Imaging. 2015 Jan; 33(1):161-5.
    View in: PubMed
    Score: 0.122
  36. Quantitative evaluation of internal marks made using MRgFUS as seen on MRI, CT, US, and digital color images - a pilot study. Phys Med. 2014 Dec; 30(8):941-6.
    View in: PubMed
    Score: 0.120
  37. Hyperthermically induced changes in high spectral and spatial resolution MR images of tumor tissue--a pilot study. Phys Med Biol. 2012 May 07; 57(9):2653-66.
    View in: PubMed
    Score: 0.104
  38. Safety limitations of MR-HIFU treatment near interfaces: a phantom validation. J Appl Clin Med Phys. 2012 Mar 08; 13(2):3739.
    View in: PubMed
    Score: 0.103
  39. T(2)* relaxation times of intraductal murine mammary cancer, invasive mammary cancer, and normal mammary gland. Med Phys. 2012 Mar; 39(3):1309-13.
    View in: PubMed
    Score: 0.103
  40. High-resolution MRI of excised human prostate specimens acquired with 9.4T in detection and identification of cancers: validation of a technique. J Magn Reson Imaging. 2011 Oct; 34(4):956-61.
    View in: PubMed
    Score: 0.100
  41. Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images. Acad Radiol. 2011 Dec; 18(12):1467-74.
    View in: PubMed
    Score: 0.100
  42. HiSStology: high spectral and spatial resolution magnetic resonance imaging detection of vasculature validated by histology and micro-computed tomography. Mol Imaging. 2011 Jun; 10(3):187-96.
    View in: PubMed
    Score: 0.096
  43. In vivo MRI of early stage mammary cancers and the normal mouse mammary gland. NMR Biomed. 2011 Aug; 24(7):880-7.
    View in: PubMed
    Score: 0.095
  44. Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model. Radiology. 2009 Nov; 253(2):399-406.
    View in: PubMed
    Score: 0.088
  45. Fourier component imaging of water resonance in the human breast provides markers for malignancy. Phys Med Biol. 2009 Oct 07; 54(19):5767-79.
    View in: PubMed
    Score: 0.087
  46. Sensitivity to tumor microvasculature without contrast agents in high spectral and spatial resolution MR images. Magn Reson Med. 2009 Feb; 61(2):291-8.
    View in: PubMed
    Score: 0.083
  47. Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study. Breast Cancer Res. 2009; 11(5):R65.
    View in: PubMed
    Score: 0.083
  48. Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation. Phys Med Biol. 2008 Oct 07; 53(19):5481-93.
    View in: PubMed
    Score: 0.081
  49. High spectral and spatial resolution MRI of age-related changes in murine prostate. Magn Reson Med. 2008 Sep; 60(3):575-81.
    View in: PubMed
    Score: 0.081
  50. Quantitative analysis of water proton spectral lineshape: a novel source of contrast in MRI. Phys Med Biol. 2008 Sep 07; 53(17):4509-22.
    View in: PubMed
    Score: 0.080
  51. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrast-enhanced MRI. Magn Reson Imaging. 2007 Jun; 25(5):593-603.
    View in: PubMed
    Score: 0.071
  52. Comparison and evaluation of mouse cardiac MRI acquired with open birdcage, single loop surface and volume birdcage coils. Phys Med Biol. 2006 Dec 21; 51(24):N451-9.
    View in: PubMed
    Score: 0.071
  53. Multi-slice DCE-MRI data using P760 distinguishes between metastatic and non-metastatic rodent prostate tumors. MAGMA. 2006 Feb; 19(1):15-21.
    View in: PubMed
    Score: 0.067
  54. Comparison of high-resolution echo-planar spectroscopic imaging with conventional MR imaging of prostate tumors in mice. NMR Biomed. 2005 Aug; 18(5):285-92.
    View in: PubMed
    Score: 0.065
  55. Quantitative Multi-Parametric MRI of the Prostate Reveals Racial Differences. Cancers (Basel). 2024 Oct 16; 16(20).
    View in: PubMed
    Score: 0.062
  56. Fourier components of inhomogeneously broadened water resonances in breast: a new source of MRI contrast. Magn Reson Med. 2004 Jul; 52(1):193-6.
    View in: PubMed
    Score: 0.060
  57. Prostate Cancers Invisible on Multiparametric MRI: Pathologic Features in Correlation with Whole-Mount Prostatectomy. Cancers (Basel). 2023 Dec 13; 15(24).
    View in: PubMed
    Score: 0.058
  58. The effect of varying spectral resolution on the quality of high spectral and spatial resolution magnetic resonance images of the breast. J Magn Reson Imaging. 2003 Oct; 18(4):442-8.
    View in: PubMed
    Score: 0.057
  59. Reduction of spectral ghost artifacts in high-resolution echo-planar spectroscopic imaging of water and fat resonances. Magn Reson Med. 2003 Jun; 49(6):1113-20.
    View in: PubMed
    Score: 0.056
  60. Standardization of Breast Dynamic Contrast-enhanced MRI Signal with Application to the Assessment of Background Parenchymal Enhancement Rate. Curr Med Imaging. 2023 Mar 06.
    View in: PubMed
    Score: 0.055
  61. Breast MR imaging with high spectral and spatial resolutions: preliminary experience. Radiology. 2002 Aug; 224(2):577-85.
    View in: PubMed
    Score: 0.053
  62. Spectrally inhomogeneous effects of contrast agents in breast lesion detected by high spectral and spatial resolution MRI. Acad Radiol. 2002 Aug; 9 Suppl 2:S352-4.
    View in: PubMed
    Score: 0.053
  63. The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth. Eur J Nucl Med Mol Imaging. 2022 Oct; 49(12):4014-4024.
    View in: PubMed
    Score: 0.053
  64. Physically implausible signals as a quantitative quality assessment metric in prostate diffusion-weighted MR imaging. Abdom Radiol (NY). 2022 07; 47(7):2500-2508.
    View in: PubMed
    Score: 0.052
  65. Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent. Acad Radiol. 2002 May; 9 Suppl 1:S115-8.
    View in: PubMed
    Score: 0.052
  66. Spectrally inhomogeneous BOLD contrast changes detected in rodent tumors with high spectral and spatial resolution MRI. NMR Biomed. 2002 Feb; 15(1):28-36.
    View in: PubMed
    Score: 0.051
  67. Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer? Acad Radiol. 2022 07; 29(7):977-985.
    View in: PubMed
    Score: 0.050
  68. Improving Tumor Hypoxia Location in 18F-Misonidazole PET with Dynamic Contrast-enhanced MRI Using Quantitative Electron Paramagnetic Resonance Partial Oxygen Pressure Images. Radiol Imaging Cancer. 2021 03; 3(2):e200104.
    View in: PubMed
    Score: 0.048
  69. Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution. Magn Reson Med. 2000 May; 43(5):633-9.
    View in: PubMed
    Score: 0.045
  70. Design, evaluation and initial imaging results of a PET insert based on strip-line readout for simultaneous PET/MRI. Nucl Instrum Methods Phys Res A. 2020 Apr 11; 959.
    View in: PubMed
    Score: 0.045
  71. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer. Abdom Radiol (NY). 2019 06; 44(6):2233-2243.
    View in: PubMed
    Score: 0.043
  72. Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study. AJR Am J Roentgenol. 2019 08; 213(2):W66-W75.
    View in: PubMed
    Score: 0.042
  73. Evaluation of Focal Laser Ablation of Prostate Cancer Using High Spectral and Spatial Resolution Imaging: A Pilot Study. J Magn Reson Imaging. 2019 05; 49(5):1374-1380.
    View in: PubMed
    Score: 0.041
  74. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer. AJR Am J Roentgenol. 2018 09; 211(3):595-604.
    View in: PubMed
    Score: 0.040
  75. Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer. Acad Radiol. 2018 03; 25(3):349-358.
    View in: PubMed
    Score: 0.038
  76. MRI of neonatal necrotizing enterocolitis in a rodent model. NMR Biomed. 2014 Mar; 27(3):272-9.
    View in: PubMed
    Score: 0.029
  77. Comparing post-operative human breast specimen radiograph and MRI in lesion margin and volume assessment. J Appl Clin Med Phys. 2012 Nov 08; 13(6):3802.
    View in: PubMed
    Score: 0.027
  78. Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis. Technol Cancer Res Treat. 2013 Feb; 12(1):71-8.
    View in: PubMed
    Score: 0.027
  79. The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast. J Magn Reson Imaging. 2011 Jun; 33(6):1382-9.
    View in: PubMed
    Score: 0.024
  80. Characterizing early contrast uptake of ductal carcinoma in situ with high temporal resolution dynamic contrast-enhanced MRI of the breast: a pilot study. Phys Med Biol. 2010 Oct 07; 55(19):N473-85.
    View in: PubMed
    Score: 0.023
  81. The use of a reference tissue arterial input function with low-temporal-resolution DCE-MRI data. Phys Med Biol. 2010 Aug 21; 55(16):4871-83.
    View in: PubMed
    Score: 0.023
  82. High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis. Magn Reson Med. 2010 Apr; 63(4):922-9.
    View in: PubMed
    Score: 0.023
  83. The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data. Magn Reson Med. 2010 Mar; 63(3):811-6.
    View in: PubMed
    Score: 0.022
  84. Relating dose of contrast media administered to uptake and washout of malignant lesions on DCEMRI of the breast. Acad Radiol. 2010 Jan; 17(1):24-30.
    View in: PubMed
    Score: 0.022
  85. Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition. AJR Am J Roentgenol. 2009 Sep; 193(3):832-9.
    View in: PubMed
    Score: 0.022
  86. Characterization of response to radiation mediated gene therapy by means of multimodality imaging. Magn Reson Med. 2009 Aug; 62(2):348-56.
    View in: PubMed
    Score: 0.022
  87. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study. Acad Radiol. 2009 Oct; 16(10):1223-30.
    View in: PubMed
    Score: 0.021
  88. DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement? Med Phys. 2008 Jul; 35(7):3102-9.
    View in: PubMed
    Score: 0.020
  89. DCEMRI of breast lesions: Is kinetic analysis equally effective for both mass and nonmass-like enhancement? Med Phys. 2008 Jul; 35(7Part1):3102-3109.
    View in: PubMed
    Score: 0.020
  90. Immobilization Using Dental Material Casts Facilitates Accurate Serial and Multimodality Small Animal Imaging. Concepts Magn Reson Part B Magn Reson Eng. 2008 Apr; 33B(2):138-144.
    View in: PubMed
    Score: 0.020
  91. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study. Magn Reson Med. 2008 Apr; 59(4):747-54.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.